Prescribing at times of clinical transition in chronic or progressive diseases

International Journal of Gerontology

Volumn 3, Issue 1, 2009, Pages 1-8

  Currow, David C ^a,b   To, Timothy H M ^b   Abernethy, Amy P ^a,b,c  

^a FLINDERS UNIVERSITY   (Australia)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chronic disease; Drug prescriptions; Drug therapy; Iatrogenic disease; Palliative care

Indexed keywords

CHRONIC DISEASE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COMORBIDITY; DISEASE EXACERBATION; FUNCTIONAL STATUS; IATROGENIC DISEASE; LONG TERM CARE; PATIENT CARE; PATIENT SATISFACTION; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; TERMINAL CARE; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

EID: 65349126371     PISSN: 18739598     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1873-9598(09)70014-6     Document Type: Review

References (16)

1. Cassel EJ. The nature of suffering and the goals of medicine. N Engl J Med 1982; 306: 639-45.
2. McCaffrey N, Eckermann S, Currow DC. Measuring impacts of value to patients is crucial when evaluating palliative care. J Pain Symptom Manage 2009 (In press).
3. Singer PA, Martin DK, Kelner M. Quality end-of-life care: patients' perspectives. JAMA 1999; 281: 163-8.
4. Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 2000; 284: 2476-82.
5. Little M. Humane Medicine. Melbourne: Cambridge University Press, 1995.
6. Abernethy AP, Shelby-James TM, Fazekas BS, Woods D, Currow DC. The Australian-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice. BMC Palliat Care 2005; 4: 7.
7. Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA 2003; 289: 2387-92.
8. Somerville MA. The Ethical Canary: Science, Society and the Human Spirit. Toronto: Viking Press, 2000.
9. Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM. Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007; 55: 590-5.
10. Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996; 14: 447-50.
11. Agar M, Currow DC, Plummer J, Seidel R, Carnahan R, Abernethy AP. Changes in anti-cholinergic load from regular prescribed medications in palliative care as death approaches. Palliat Med 2009 (In press).
12. Eagar K, Green J, Gordon R. An Australian casemix classification for palliative care: technical development and results. Palliat Med 2004; 18: 217-26.
13. Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 2008; 56: 1946-52.
14. Stevenson J, Abernethy AP, Miller C, Currow DC. Managing comorbidities in patients at the end of life. BMJ 2004; 329: 909-12.
15. Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 2007; 5: 31-9.
16. Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993; 329: 1-7.